Fig. 1From: One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatmentFlow diagram of the clinical trial for severe COVID-19 patients. Abbreviations: hUC-MSCs: human umbilical cord mesenchymal stem cells; COVID-19: coronavirus disease 2019Back to article page